- Poruka
- 91.063
Ovo je sve što treba da znate o "pakslovidu"
https://www.blic.rs/vesti/drustvo/l...campaign=push_cfa23dbb0a8115b&utm_medium=push
-
- Popularno:
- 10 Najnezdravijih namirnica na planeti
- Alergija na kikiriki – nimalo bezazlena...
- Зло модерних феминисткиња...
- Русофили, да вас нешто питам....
- Zasto mnogi pricaju da su Evropljanke...
- Zašto nikad neću da glasam za Europejce...
- Tepić pozvala na dogovor oko tehničke...
- Kako brzo uočiš da je neko glup?
- Čedomir Čupić treba da bude kandidat...
- Režimski Kurir i Režimski plaćenici...
Fajzer: Pilula protiv kovida smanjuje rizik od teškog zaražavanja za 89%
- Začetnik teme Straks92
- Datum pokretanja
https://www.blic.rs/vesti/drustvo/l...campaign=push_cfa23dbb0a8115b&utm_medium=push
The Indian Express reported:
FLASHBACK: Uttar Pradesh Government in India Publicly Claims Early Use of Ivermectin Helped State Maintain Lower COVID-19 Cases and Deaths
UPDATE: 71 out of 75 Districts in Uttar Pradesh, India – Its Most Populated State – Reported No Covid-19 Cases in 24 Hours After Implementing Ivermectin Protocol
a taj drugi je?
mislim kako da znamo leci li i taj drugi i koliko, ili da nije mozda taj drugi jedini i lek? da ne pocinje na i?
obicno se pacijenti podele na dve grupe, a druga je kontrolna koja dobija taj drugi lek, a sada prvi put cujem da se istima daje i drugi, misteriozni lek
ja bih ako moze da kupim taj drugi kojim su pacijenti bili leceni zajedno sa prvim, a prvi bi da preskocim ako ne zamerate, po prirodi sam nepoverljiv, nista licno, nemo' se vredjate ako bajagu znate: pilule za lilule
Poslednja izmena:
- Poruka
- 91.063
- Poruka
- 1.085
Da lek je eksperimentalni i na Srbima se ispituje besplatno...
Da ne bude da su nas samo (pro)dali Istoku za eksperiment....evo dadose nas i Zapadu:
Idemo opet na provakserski Index:
Srbija će koristiti Pfizerov eksperimentalni lijek za koronu
https://www.index.hr/vijesti/clanak...eksperimentalni-lijek-za-koronu/2316739.aspxž
Ovo je prepakovani Iverkemtin btw...samo sto nije 2 dolara vec ko zna koliko....
Dakle više se i ne krije da je nesto eksperimentalno...do skora su se bar od te reci suzdrzavali...sad se vise i ne osvrcu...
....
- Poruka
- 23.368
Pitanje kad ce ugledati svetlost dana. Da li ce biti dovoljna jedna ili vise?
Kad se setim reči vakcina je zivot, spas.
Kad se setim reči vakcina je zivot, spas.
The_Night_Hawk
Cloud surfer
- Poruka
- 81.633
Rec ZARAZAVANJE ne postoji.
Covek moze da se zarazi necim a ne ZARAZAVA,
Ostalo je jos veca prevara...
Covek moze da se zarazi necim a ne ZARAZAVA,
Ostalo je jos veca prevara...
reported:
“Due to the Omicron variant and the short supply of COVID therapeutics, NIH recommends certain therapies over others for patients at high risk of progressing to severe COVID,” said federal officials on a call with clinicians Wednesday [January 12].
“In order of preference, clinicians should use the oral antiviral nirmatrelvir-ritonavir (Paxlovid), the monoclonal antibody sotrovimab, the IV antiviral remdesivir (Veklury) and finally, the oral antiviral molnupiravir,” said Alice Pau, PharmD, of the NIH COVID-19 Treatment Guidelines panel.
“While the drugs were ranked from 1 to 4, she noted that nirmatrelvir-ritonavir, sotrovimab, and IV remdesivir three times a day all had similar clinical efficacy, with a relative risk reduction of 88%, 85%, and 87% in hospitalizations and deaths, respectively, versus placebo. However, molnupiravir, with its 30% efficacy, should be used only if the other three choices are not available,” Pau noted.
https://noqreport.com/2022/01/20/new-nih-covid-treatment-guidelines-worse-than-useless/
Here are the main reasons why the NIH list of preferred COVID treatments should not reassure the public:
“Due to the Omicron variant and the short supply of COVID therapeutics, NIH recommends certain therapies over others for patients at high risk of progressing to severe COVID,” said federal officials on a call with clinicians Wednesday [January 12].
“In order of preference, clinicians should use the oral antiviral nirmatrelvir-ritonavir (Paxlovid), the monoclonal antibody sotrovimab, the IV antiviral remdesivir (Veklury) and finally, the oral antiviral molnupiravir,” said Alice Pau, PharmD, of the NIH COVID-19 Treatment Guidelines panel.
“While the drugs were ranked from 1 to 4, she noted that nirmatrelvir-ritonavir, sotrovimab, and IV remdesivir three times a day all had similar clinical efficacy, with a relative risk reduction of 88%, 85%, and 87% in hospitalizations and deaths, respectively, versus placebo. However, molnupiravir, with its 30% efficacy, should be used only if the other three choices are not available,” Pau noted.
https://noqreport.com/2022/01/20/new-nih-covid-treatment-guidelines-worse-than-useless/
Here are the main reasons why the NIH list of preferred COVID treatments should not reassure the public:
- The first preferred action, using the Pfizer drug Paxlovid, makes little sense because there is nearly no availability of it. And even if people could get prescriptions filled, would they be acting fast enough to get benefits? In the clinical trials people had to start the drug within three days of symptoms even though they now talk of starting within five days; that too is totally impractical and unrealistic. Few people would be able to distinguish symptoms being COVID and not the flu or a bad cold quickly, getting an appointment with the doctor quickly and getting a prescription filled quickly. And the safety has not been adequately assessed.
- The monoclonal antibody sotrovimab is nearly impossible to get because of extremely limited supply. And here too, a sick person would have to get medical attention quickly, that is extremely difficult. Even your local hospital might not have it.
- The very expensive drug remdesivir has a terrible history of being both ineffective and having terrible side effects. It is mostly given to very ill patients in hospitals.
- Then you get to the absolutely ludicrous fourth option, the new Merck antiviral that has a terrible level of effectiveness and that has not been proven safe. An absolutely awful choice.
- Poruka
- 82.950
A što srbe tretiraju kao laboratorijske pacove? Ko god nešto izmisli odmah se šalje za srbiju da se testira?!??
The_Night_Hawk
Cloud surfer
- Poruka
- 81.633
Ако неко провали да се и од ове пилуле диже кита, сви ће да потрче...
koja je logika da se daje remdesivir ako szo kaze da je jednako bezvredan kao i hidroksi?
https://www.who.int/emergencies/dis...darity-clinical-trial-for-covid-19-treatments
https://www.nejm.org/doi/full/10.1056/nejmoa2023184
zato sto vas u zdrav mozak kljucaju, ovo precutkuju;
cink ubija virus, a hcq ili iver su samo vozila za taj cink, ili puske za metak, ako je cink nazvan metkom
Dr. Zelenko:
“Zinc is the bullet – it kills the virus. The only problem is the bullet doesn’t get to the place where it needs to be.The virus is inside the cell. The enzyme is inside the cell. And the zinc on its own cannot get into the cell. You have a bullet without a gun – useless.
Now, it turns out there’s a class of medications called ‘zinc ionophores’ or a class of substances called ‘zinc ionophores’ — what they do — is they open up a channel, a door, which allows zinc to go from outside the cell to inside the cell.
There are four of them that are readily available – two of them are prescription and two of them are over-the-counter.
The two prescription ones everyone has heard of: Hydroxycholorquine and Ivermection.
They’re the guns that shoot the bullet.
Pfizer are omitting to state the primary purpose of Ritonavir, which is that of a well established FDA approved Protease inhibitor used to treat HIV.
“Ritonavir is 1 of the 4 potent synthetic HIV protease inhibitors, approved by the US Food and Drug Administration (FDA) between 1995 and 1997, that have revolutionised HIV therapy” – – https://pubmed.ncbi.nlm.nih.gov/9812178/
aha, mala doza? e, pa ako je mala onda u redu
anti-HIV drug Ritonavir is 89% effective in treating Covid and that the imaginatively named PF-07321332 is only there to disguise that revelation and to slow down the metabolism by the body of Ritonavir. Pfizer are calling the combination PAXLOVID.
Poslednja izmena od moderatora:
cekaj, zar nije zelenko rekao da je to da je cink jonoforu, tj dopremanje i ulazak cinka u celiju, prepisao sa NIH sajta, samo se radi o drugoj supstanci, kvercetinu, koji opet ima istu funkciju kao iver i hidroksi, CITIRAM:
i sta sada ti nama nudis?
Pa dobro, a zasto je onda nasim penzionerima podeljen D vitamin, i zasto ga je indija delila? Milsim, zar su svi oni navuceni konspiracionistima gateway pundit? zaista neozbiljno.
Poslednja izmena:
jel si uspeo da saznas koji je taj drugi antivirusni lek?
da li neko od vas diskutanata zna koji je taj drugi antivirusni lek i protiv koje virusne bolesti je pokazao odlicne rezultate?
ja znam, i znam zasto se krije koji je taj drugi.
- Poruka
- 9.626
Тај ,,неки" интернационални fact-checking сајт је у власништву Poynter института, а ти га поредиш са једним Гејтвеј Пундитом.
Ма, све ти знаш, паметна моја главице, знаш и све што се крије и зашто се крије, све ти знаш, па теби се ЦИА обраћа за обавештајне податке.
posteno da ti kazem ja osim ruganja ne videh da si mi odgovorio
ocekujes da budem impresioniram medijem, novinskom kucom, koja pljuje druge medije zajedno sa tobom?
pa gde je tu diskusija argumentovana, gde je replika na NIH PEER REVIEWED STUDIJU, koja se pominje kao argument u prilog jonofori cinka?
nisi ozbiljan.
